Onglyza and Panic disorder - a phase IV clinical study of FDA data

Summary:

Panic disorder is reported as a side effect among people who take Onglyza (saxagliptin hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Lyrica, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Panic disorder when taking Onglyza. It is created by eHealthMe based on reports of 8,520 people who have side effects when taking Onglyza from the FDA, and is updated regularly.

What is Onglyza?

Onglyza has active ingredients of saxagliptin hydrochloride. It is often used in diabetes. eHealthMe is studying from 8,638 Onglyza users. Check the latest studies of Onglyza.

What is Panic disorder?

Panic disorder is found to be associated with 1,669 drugs and 2,055 conditions by eHealthMe. Check the latest studies of Panic disorder.

On Jul, 09, 2026

8,520 people reported to have side effects when taking Onglyza.
Among them, 12 people (0.14%) have Panic disorder.

Among these 12 people:

How long have people been on Onglyza when they have Panic disorder? *

What is the gender of people who have Panic disorder when taking Onglyza? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Panic disorder when taking Onglyza? *

What are other drugs people take besides Onglyza? *

What are other side effects people have besides Panic disorder? *

Abdominal Pain Upper: 5 people, 41.67%
Stress And Anxiety: 5 people, 41.67%
Pain: 4 people, 33.33%
Activities Of Daily Living Impaired: 2 people, 16.67%
Dehydration (dryness resulting from the removal of water): 2 people, 16.67%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 8.33%
Hyperventilation: 1 person, 8.33%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 1 person, 8.33%
Headache (pain in head): 1 person, 8.33%
Fear: 1 person, 8.33%

What are the existing conditions these people have? *

High Blood Cholesterol: 5 people, 41.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 41.67%
Pain: 4 people, 33.33%
Asthma: 4 people, 33.33%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 33.33%
Muscle Spasms (muscle contraction): 4 people, 33.33%
Swelling: 4 people, 33.33%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 33.33%
Stress And Anxiety: 2 people, 16.67%
Cardiac Disorder: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Onglyza and have Panic disorder?

- Check whether Panic disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Onglyza:

Onglyza (8,638 reports)

Panic disorder treatments and more:

Panic disorder (65,704 reports)

Browse all side effects of Onglyza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic disorder:

Panic disorder (1,669 drugs)

Browse all the conditions that are associated with Panic disorder:

Panic disorder (2,055 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on saxagliptin hydrochloride (the active ingredients of Onglyza) and Onglyza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.